D.E. Shaw & Co’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.9M | Buy |
|
|||||
|
2025
Q1 | $15.3M | Sell |
|
|||||
|
2024
Q4 | $19.7M | Buy |
|
|||||
|
2024
Q3 | $12.7M | Buy |
|
|||||
|
2024
Q2 | $7.78M | Buy |
|
|||||
|
2024
Q1 | $4.45M | Buy |
|
|||||
|
2023
Q4 | $3.74M | Buy |
|
|||||
|
2023
Q3 | $690K | Buy |
|
|||||
|
2023
Q2 | $736K | Sell |
|
|||||
|
2023
Q1 | $1.06M | Sell |
|
|||||
|
2022
Q4 | $1.05M | Buy |
|
|||||
|
2022
Q3 | $921K | Buy |
|
|||||
|
2022
Q2 | $466K | Buy |
|
|||||
|
2022
Q1 | $250K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $306K | Sell |
|
|||||
|
2021
Q1 | $387K | Sell |
|
|||||
|
2020
Q4 | $539K | Sell |
|
|||||
|
2020
Q3 | $2.89M | Sell |
|
|||||
|
2020
Q2 | $5.5M | Buy |
|
|||||
|
2020
Q1 | $4.11M | Buy |
|
|||||
|
2019
Q4 | $3.77M | Buy |
|
|||||
|
2019
Q3 | $360K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $965K | Sell |
|
|||||
|
2018
Q4 | $1.76M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $339K | Sell |
|
|||||
|
2017
Q4 | $496K | Sell |
|
|||||
|
2017
Q3 | $514K | Sell |
|
|||||
|
2017
Q2 | $743K | Sell |
|
|||||
|
2017
Q1 | $564K | Sell |
|
|||||
|
2016
Q4 | $570K | Buy |
|
|||||
|
2016
Q3 | $340K | Sell |
|
|||||
|
2016
Q2 | $315K | Sell |
|
|||||
|
2016
Q1 | $336K | Sell |
|
|||||
|
2015
Q4 | $348K | Sell |
|
|||||
|
2015
Q3 | $1.12M | Sell |
|
|||||
|
2015
Q2 | $2.01M | Buy |
|
|||||
|
2015
Q1 | $125K | Sell |
|
|||||
|
2014
Q4 | $314K | Sell |
|
|||||
|
2014
Q3 | $596K | Sell |
|
|||||
|
2014
Q2 | $1.38M | Sell |
|
|||||
|
2014
Q1 | $1.36M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $246K | Buy |
|